Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications.

Source:http://linkedlifedata.com/resource/pubmed/id/12764641

Download in:

View as

General Info

PMID
12764641